Oncology research network adds four new members
Click Here to Manage Email Alerts
The Oncology Research Information Exchange Network, anchored by Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, recently added four new members.
The new members are City of Hope, University of Virginia Cancer Center, University of Colorado Cancer Center and University of New Mexico Cancer Center.
The ORIEN network provides an extensive database with patient information — including medical histories, cancer tissue and DNA — that can be used for basic research and clinical trials. the expansion is expected to considerably increase the number of patients consenting to donate their tissue and clinical data — including corresponding genomic data — for research to understand cancer at the molecular level, with the goal of developing more targeted cancer treatments.
“With the addition of [the four new member institutions], more than 50,000 new patients each year will have the opportunity to consent to donate their tissue and clinical data to the ORIEN network, and potentially be matched with ongoing clinical research with the most potential to help them,” Thomas Sellers, PhD, MPH, center director and executive vice president of Moffitt, said in a press release. “Each of these renowned National Cancer Institute-designated cancer centers will enhance our collaborative model, which greatly reduces the amount of time required to conduct clinical trials.”
Steven T. Rosen
The network allows institutions to achieve considerably more than they could independently, according to Steven T. Rosen, MD, provost and chief scientific officer for City of Hope and director of the City of Hope Comprehensive Cancer Center.
“Rapidly evolving science and modern diagnostics are moving the field of cancer research and cures forward, but it’s not something one institution can accomplish on its own,” Rosen said in a press release. “City of Hope is proud to partner with Moffitt, the OSUCCC-James and the new ORIEN members to share data, collaborate and to ultimately change the cancer treatment model.”